久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

^{<blockquote id="6frzz"></blockquote>}<style id="6frzz"></style><sub id="6frzz"></sub>

You are here: Industry Insights > cancer therapies

News List

Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation AmericanPharmaceuticalReview
December 02, 2021
Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, today announced an agreement with Pfizer Inc. to apply and evaluate Ranok’s CHAMP? platfor...
CRISPR and MaxCyte sign licensing deal for cancer therapies pharmaceutical-technology
November 13, 2018
Swiss gene editing firm CRISPR Therapeutics has signed a non-exclusive commercial licence agreement with US-based drug maker MaxCyte for the development of new immuno-oncology therapies.
Race and TargImmune to develop new cancer therapies pharmaceutical-technology
July 12, 2017
Australian-based specialist pharmaceutical firm Race Oncology has executed a Letter of Intent (LoI) with Swiss-based biotechnology TargImmune Therapeutics to enter a joint venture (JV) between the two companies to develop new and improved cancer therapies